A late-breaking study drawing on more than 15 years of national outcomes data from the STS Adult Cardiac Surgery Database ...
More representative trial populations and standardized subgroup reporting are needed in non–small cell lung cancer (NSCLC) research, according to a meta-analysis published in Cancers, which found no ...
ACE inhibitor use was associated with reduced all cause mortality in idiopathic pulmonary fibrosis in a matched real world ...
Real world data show multiple myeloma survival varies by treatment line and autologous stem cell transplant status. Read more ...
With a median follow-up of 4.2 years, patients receiving blinatumomab achieved a 4-year disease-free survival (DFS) of 83.3% ...
Angiotensin-converting enzyme (ACE) inhibitors were found to be independently associated with reducing all-cause mortality in ...
GLP-1 RA use is associated with improved survival and lower hospitalization rates in patients with type 2 diabetes receiving cancer therapy.
Objectives This study examined discharge outcomes and their predictors among patients enrolled in remote patient monitoring (RPM) support in Ontario, Canada. Design A 6-month competing risk survival ...
Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.
Cleveland Clinic researchers have found that nearly two-thirds of patients with HER2-positive metastatic breast cancer did ...
A massive iceberg has triggered a catastrophic die-off of Emperor Penguin chicks in Antarctica, blocking thousands of parents ...
Investigators compared clinical outcomes with docetaxel rechallenge vs cabazitaxel in patients with mCRPC who did not experience disease progression during prior administration of docetaxel for mCRPC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results